Experiment: 2RRK

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1mM [U-99% 15N] entity-1; 50mM potassium phosphate-2; 20mM potassium chloride-3; 1mM DTT-4; 0.1mM EDTA-5; 93% H2O/7% D2O	93% H2O/7% D2O	70	6.9	ambient	303
2	3D HNCACB	1mM [U-99% 13C; U-99% 15N] entity-6; 50mM potassium phosphate-7; 20mM potassium chloride-8; 1mM DTT-9; 0.1mM EDTA-10; 93% H2O/7% D2O	93% H2O/7% D2O	70	6.9	ambient	303
3	3D HN(COCA)CB	1mM [U-99% 13C; U-99% 15N] entity-6; 50mM potassium phosphate-7; 20mM potassium chloride-8; 1mM DTT-9; 0.1mM EDTA-10; 93% H2O/7% D2O	93% H2O/7% D2O	70	6.9	ambient	303
4	3D HN(CA)CO	1mM [U-99% 13C; U-99% 15N] entity-6; 50mM potassium phosphate-7; 20mM potassium chloride-8; 1mM DTT-9; 0.1mM EDTA-10; 93% H2O/7% D2O	93% H2O/7% D2O	70	6.9	ambient	303
5	3D HNCO	1mM [U-99% 13C; U-99% 15N] entity-6; 50mM potassium phosphate-7; 20mM potassium chloride-8; 1mM DTT-9; 0.1mM EDTA-10; 93% H2O/7% D2O	93% H2O/7% D2O	70	6.9	ambient	303
6	3D HCCH-TOCSY	1mM [U-99% 13C; U-99% 15N] entity-11; 50mM potassium phosphate-12; 20mM potassium chloride-13; 1mM DTT-14; 0.1mM EDTA-15; 100% D2O	100% D2O	70	6.9	ambient	303
7	3D H(CCO)NH	1mM [U-99% 13C; U-99% 15N] entity-6; 50mM potassium phosphate-7; 20mM potassium chloride-8; 1mM DTT-9; 0.1mM EDTA-10; 93% H2O/7% D2O	93% H2O/7% D2O	70	6.9	ambient	303
8	3D C(CO)NH	1mM [U-99% 13C; U-99% 15N] entity-6; 50mM potassium phosphate-7; 20mM potassium chloride-8; 1mM DTT-9; 0.1mM EDTA-10; 93% H2O/7% D2O	93% H2O/7% D2O	70	6.9	ambient	303
9	4D HC(CO)NH	1mM [U-99% 13C; U-99% 15N] entity-6; 50mM potassium phosphate-7; 20mM potassium chloride-8; 1mM DTT-9; 0.1mM EDTA-10; 93% H2O/7% D2O	93% H2O/7% D2O	70	6.9	ambient	303
10	3D 1H-13C NOESY aliphatic	1mM [U-99% 13C; U-99% 15N] entity-11; 50mM potassium phosphate-12; 20mM potassium chloride-13; 1mM DTT-14; 0.1mM EDTA-15; 100% D2O	100% D2O	70	6.9	ambient	303
11	3D 1H-15N NOESY	1mM [U-99% 15N] entity-1; 50mM potassium phosphate-2; 20mM potassium chloride-3; 1mM DTT-4; 0.1mM EDTA-5; 93% H2O/7% D2O	93% H2O/7% D2O	70	6.9	ambient	303
12	2D 15N filtered NOESY	1mM [U-99% 15N] entity-1; 50mM potassium phosphate-2; 20mM potassium chloride-3; 1mM DTT-4; 0.1mM EDTA-5; 93% H2O/7% D2O	93% H2O/7% D2O	70	6.9	ambient	303
13	3D HNHA	1mM [U-99% 15N] entity-1; 50mM potassium phosphate-2; 20mM potassium chloride-3; 1mM DTT-4; 0.1mM EDTA-5; 93% H2O/7% D2O	93% H2O/7% D2O	70	6.9	ambient	303

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	500
2	Bruker	AVANCE	600
3	Bruker	DRX	800

NMR Refinement
Method	Details	Software
simulated annealing		XwinNMR

NMR Ensemble Information
Conformer Selection Criteria	structures with favorable non-bond energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	XwinNMR		Bruker Biospin
2	collection	TopSpin		Bruker Biospin
3	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
4	data analysis	TALOS		Cornilescu, Delaglio and Bax
5	peak picking	Sparky		Goddard
6	data analysis	Sparky		Goddard
7	chemical shift assignment	Sparky		Goddard
8	structure solution	CYANA		Guntert, Mumenthaler and Wuthrich
9	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.